Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults

Addiction Biology

Volumn 21, Issue 1, 2016, Pages 125-135

  Hendershot, Christian S ^a,b   Claus, Eric D ^c   Ramchandani, Vijay A ^d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MIND RESEARCH NETWORK   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Asn40Asp; pharmacogenetics; phenotype; rs1799971; SNP; subjective responses to alcohol

Indexed keywords

ALCOHOL; CENTRAL DEPRESSANT AGENT; MU OPIATE RECEPTOR; OPRM1 PROTEIN, HUMAN;

ADULT; ALCOHOL USE DISORDER; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; FEMALE; GENE; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRAVENOUS ALCOHOL SELF ADMINISTRATION; INTRAVENOUS DRUG ABUSE; MALE; OPRM1 GENE; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; SEX DIFFERENCE; ALCOHOL INTOXICATION; ALCOHOLISM; BREATH ANALYSIS; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ALCOHOL-RELATED DISORDERS; ALCOHOLIC INTOXICATION; BREATH TESTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU; SELF ADMINISTRATION; YOUNG ADULT;

EID: 84957439392     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12165     Document Type: Article

References (54)

1. Anton RF, Voronon KK, Randall PK, Myrick H, Tiffany A, (2012) Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopmapine transporter (SLC6A3) genes. Alcohol Clin Exp Res 36: 2000-2007.
2. Arias A, Feinn R, Kranzler HR, (2006) Association of an Asn40Asp (A118G) polymorphism in the μ-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend 83: 262-268.
3. Barr CS, Chen SA, Schwandt ML, Lindell SG, Sun H, Suomi SJ, Heilig M, (2010) Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus. Biol Psychiatry 67: 78-80.
4. Barr CS, Schwandt M, Lindell SG, Chen SA, Goldman D, Suomi SJ, Higley JD, Heilig M, (2007) Association of a functional polymorphism in the μ-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry 64: 369-376.
5. Bartholow BD, Henry EA, Lust SA, (2007) Effects of alcohol sensitivity on P3 event-related potential reactivity to alcohol cues. Psychol Addict Behav 21: 555-563.
6. Bartholow BD, Pearson M, Sher KJ, Wieman LC, Fabiani M, Gratton G, (2003) Effects of alcohol consumption and alcohol susceptibility on cognition: a psychophysiological examination. Biol Psychol 64: 167-190.
7. Bohn MJ, Krahn DD, Staehler BA, (1995) Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19: 600-606.
8. Crabbe JC, Bell RL, Ehlers CL, (2010) Human and laboratory rodent low response to alcohol: is better consilience possible? Addict Biol 15: 125-144.
9. de Wit H, Pierri J, Johanson CE, (1989) Assessing individual differences in ethanol preference using a cumulative dosing procedure. Psychopharmacology (Berl) 98: 113-119.
10. de Wit H, Uhlenhuth EH, Pierri J, Johanson CE, (1987) Individual differences in behavioral and subjective responses to alcohol. Alcohol Clin Exp Res 11: 52-59.
11. Enoch MA, Schuckit MA, Johnson BA, Goldman D, (2003) Genetics of alcoholism using intermediate phenotypes. Alcohol Clin Exp Res 27: 169-176.
12. Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE, (2008) Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res 32: 1113-1123.
13. Heilig M, Goldman D, Berrettini W, O'Brien CP, (2011) Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 12: 670-684.
14. Hines LM, Ray L, Hutchison K, Tabakoff B, (2005) Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci 7: 153-163.
15. Kalant H, (2010) What neurobiology cannot tell us about addiction. Addiction 105: 780-789.
16. Kareken DA, Bragulat V, Dzemidzic M, Cox C, Talavage T, Davidson D, O'Connor SJ, (2010) Family history of alcoholism mediates the frontal response to alcoholic drink odors and alcohol in at-risk drinkers. Neuroimage 50: 267-276.
17. King AC, de Wit H, McNamara PJ, Cao D, (2011a) Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Arch Gen Psychiatry 68: 389-399.
18. King AC, Roche DJ, Rueger SY, (2011b) Subjective responses to alcohol: a paradigm shift may be brewing. Alcohol Clin Exp Res 35: 1726-1728.
19. Kranzler HR, Armeli S, Covault J, Tennen H, (2013) Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment. Addict Biol 18: 193-201.
20. Leeman RF, Heilig M, Cunningham CL, Stephens DN, Duka T, O'Malley SS, (2010) Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes. Addict Biol 15: 109-124.
21. Li TK, Hewitt BG, Grant BF, (2004) Alcohol use disorders and mood disorders: a National Institute on Alcohol Abuse and Alcoholism perspective. Biol Psychiatry 56: 718-720.
22. Mague SD, Blendy JA, (2010) OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend 108: 172-182.
23. Marlatt GA, Demming B, Reid JB, (1973) Loss of control drinking in alcoholics: an experimental analogue. J Abnorm Psychol 81: 233-241.
24. Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM, (1993) Development and validation of the biphasic alcohol effects scale. Alcohol Clin Exp Res 17: 140-146.
25. McGeary JE, Monti PM, Rohsenow DJ, Tidey J, Swift R, Miranda R Jr., (2006) Genetic moderators of naltrexone's effects on alcohol cue reactivity. Alcohol Clin Exp Res 30: 1288-1296.
26. McKee SA, (2009) Developing human laboratory models of smoking lapse behavior for medication screening. Addict Biol 14: 99-107.
27. Mello NK, Mendelson JH, (1965) Operant analysis of drinking patterns of chronic alcoholics. Nature 206: 43-46.
28. Miranda R, Ray L, Justus A, Meyerson LA, Knopik VS, McGeary J, Monti PM, (2010) Initial evidence of an association between OPRM1 and adolescent alcohol misuse. Alcohol Clin Exp Res 34: 112-122.
29. Morean ME, Corbin WR, (2010) Subjective response to alcohol: a critical review of the literature. Alcohol Clin Exp Res 34: 385-395.
30. Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O'Malley SS, (2013) The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology (Berl) 227: 177-192.
31. National Institute on Alcohol Abuse and Alcoholism (2004) NIAAA Council Approves Definition of Binge Drinking. NIAAA Newsletter: Winter. Available at: http://pubs.niaaa.nih.gov/publications/Newsletter/winter2004/Newsletter-Number3.pdf. Accessed 23 December 2013.
32. O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ, (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) 160: 19-29.
33. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP, (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28: 1546-1552.
34. Plawecki MH, Han JJ, Doerschuk PC, Ramchandani VA, O'Connor SJ, (2008) Physiologically based pharmacokinetic (PBPK) models for ethanol. IEEE Trans Biomed Eng 55: 2691-2700.
35. Plawecki MH, Wetherill L, Vitvitskiy V, Kosobud A, Zimmermann US, Edenberg HJ, O'Connor S, (2013) Voluntary intravenous self-administration of alcohol detects an interaction between GABAergic manipulation and GABRG1 polymorphism genotype: a pilot study. Alcohol Clin Exp Res 37 (Suppl. 1): E152-E160.
36. Plebani JG, Ray LA, Morean ME, Corbin WR, MacKillop J, Amlung M, King AC, (2012) Human laboratory paradigms in alcohol research. Alcohol Clin Exp Res 36: 972-983.
37. Ramchandani VA, Bolane J, Li TK, O'Connor S, (1999) A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping. Alcohol Clin Exp Res 23: 617-623.
38. Ramchandani VA, O'Connor S, (2006) Studying alcohol elimination using the alcohol clamp method. Alcohol Res Health 29: 286-290.
39. Ramchandani VA, Plawecki M, Li TK, O'Connor S, (2009) Intravenous ethanol infusions can mimic the time course of breath alcohol concentrations following oral alcohol administration in healthy volunteers. Alcohol Clin Exp Res 33: 938-944.
40. Ramchandani VA, Umhau J, Pavon FJ, Ruiz-Velasco V, Margas W, Sun H, Damadzic R, Eskay R, Schoor M, Thorsell A, Schwandt ML, Sommer WH, George DT, Parsons LH, Herscovitch P, Hommer D, Heilig M, (2011) A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 16: 809-817.
41. Ray LA, Hutchison KE, (2004) A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28: 1789-1795.
42. Ray LA, Hutchison KE, (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64: 1069-1077.
43. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF, (2012a) The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res 36: 385-394.
44. Ray LA, Bujarski S, Chin PF, Miotto K, (2012b) Pharmacogenetics of naltrexone in Asian Americans: a randomized placebo-controlled laboratory study. Neuropsychopharmacology 37: 445-455.
45. Ray LA, Hutchison KE, Tartter M, (2010) Application of human laboratory models to pharmacotherapy development for alcohol dependence. Curr Pharm Des 16: 2149-2158.
46. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M, (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88: 791-804.
47. Setiawan E, Pihl RO, Cox SM, Gianoulakis C, Palmour RM, Benkelfat C, Leyton M, (2011) The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype. Alcohol Clin Exp Res 35: 1134-1141.
48. Sobell LC, Sobell MB, (1992) Timeline follow-back: a technique for assessing self-reported alcohol consumption. In:, Litten RZ, Allen JP, eds. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods, pp. 41-72. Totowa, NJ: Humana Press.
49. van den Wildenberg E, Wiers RW, Dessers J, Janssen RG, Lambrichs EH, Smeets HJ, van Breukelen GJ, (2007) A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. Alcohol Clin Exp Res 31: 1-10.
50. Vallender EJ, Ruedi-Bettschen D, Miller GM, Platt DM, (2010) A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys. Drug Alcohol Depend 109: 252-256.
51. Wiers RW, Rinck M, Dictus M, van den Wildenberg E, (2009) Relatively strong automatic appetitive action-tendencies in male carriers of the OPRM1 G-allele. Genes Brain Behav 8: 101-106.
52. Zimmermann US, Mick I, Laucht M, Vitvitskiy V, Plawecki MH, Mann KF, O'Connor S, (2009) Offspring of parents with an alcohol use disorder prefer higher levels of brain alcohol exposure in experiments involving computer-assisted self-infusion of ethanol (CASE). Psychopharmacology (Berl) 202: 689-697.
53. Zimmermann US, Mick I, Vitvitskyi V, Plawecki MH, Mann KF, O'Connor S, (2008) Development and pilot validation of computer-assisted self-infusion of ethanol (CASE): a new method to study alcohol self-administration in humans. Alcohol Clin Exp Res 32: 1321-1328.
54. Zimmermann US, O'Connor S, Ramchandani VA, (2013) Modeling alcohol self-administration in the human laboratory. Curr Top Behav Neurosci 13: 315-353.